DAFNA Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.58M | Sell |
|
|||||
|
2025
Q1 | $8.68M | Sell |
|
|||||
|
2024
Q4 | $6.87M | Buy |
|
|||||
|
2024
Q3 | $8.38M | Sell |
|
|||||
|
2024
Q2 | $9.51M | Hold |
|
|||||
|
2024
Q1 | $9.57M | Buy |
|
|||||
|
2023
Q4 | $7.36M | Sell |
|
|||||
|
2023
Q3 | $5.83M | Sell |
|
|||||
|
2023
Q2 | $5.5M | Sell |
|
|||||
|
2023
Q1 | $4.84M | Hold |
|
|||||
|
2022
Q4 | $4.16M | Buy |
|
|||||
|
2022
Q3 | $3.71M | Sell |
|
|||||
|
2022
Q2 | $2.61M | Buy |
|
|||||
|
2022
Q1 | $2.81M | Hold |
|
|||||
|
2021
Q4 | $2.52M | Buy |
|
|||||
|
2021
Q3 | $3.3M | Buy |
|
|||||
|
2021
Q2 | $1.45M | Buy |
|
|||||
|
2021
Q1 | $1.5M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.62M | Sell |
|
|||||
|
2020
Q2 | $2.69M | Sell |
|
|||||
|
2020
Q1 | $1.8M | Buy |
|
|||||
|
2019
Q4 | $440K | Hold |
|
|||||
|
2019
Q3 | $287K | Hold |
|
|||||
|
2019
Q2 | $548K | Buy |
|
|||||
|
2019
Q1 | $665K | Buy |
|
|||||
|
2018
Q4 | $399K | Buy |
|
|||||
|
2018
Q3 | $392K | Buy |
|